Sequential Treatment with Intermittent Low-Dose Human Parathyroid Hormone (1-34) and Bisphosphonate Enhances Large-Size Skeletal Reconstruction by Vascularized Bone Transplantation

Author： Hashimoto Takahiro   Shigetomi Mitsunori   Ohno Teruyasu   Matsunaga Tsunemitsu   Muramatsu Keiichi   Tanaka Hiroshi   Sugiyama Toshihiro   Taguchi Toshihiko  

Publisher： Springer Publishing Company

ISSN： 0171-967X

Source： Calcified Tissue International, Vol.81, Iss.3, 2007-09, pp. : 232-239

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Atorvastatin enhances bone density in ovariectomized rats given 17β-estradiol or human parathyroid hormone(1–34)

By Kawane Tetsuya   Terashima Shinichi   Kurahashi Izuru   Yanagawa Toru   Yoshida Hiroshi   Horiuchi Noboru  

Endocrine Journal, Vol. 24, Iss. 2, 2004-07 ,pp. : 121-129

Humana Press, Inc

Access to resources Recommend Favorite

Daily Treatment of Aged Ovariectomized Rats with Human Parathyroid Hormone (1-84) for 12 Months Reverses Bone Loss and Enhances Trabecular and Cortical Bone Strength

By Fox J.   Miller M.   Newman M.   Metcalfe A.   Turner C.   Recker R.   Smith S.  

Calcified Tissue International, Vol. 79, Iss. 4, 2006-10 ,pp. : 262-272

Springer Publishing Company

Access to resources Recommend Favorite

Comparison of the effects of raloxifene and low-dose hormone replacement therapy on bone mineral density and bone turnover in the treatment of postmenopausal osteoporosis

By Dane Cem   Dane Banu   Cetin Ahmet   Erginbas Murat  

Gynecological Endocrinology, Vol. 23, Iss. 7, 2007-07 ,pp. : 398-403

Informa Healthcare

Access to resources Recommend Favorite

Circulating Fibroblast Growth Factor 23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

By Mahon James  

Calcified Tissue International, Vol. 88, Iss. 6, 2011-06 ,pp. : 530-530

Springer Publishing Company

Access to resources Recommend Favorite

Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

By Hampson Geeta  

Calcified Tissue International, Vol. 88, Iss. 6, 2011-06 ,pp. : 531-531

Springer Publishing Company

Access to resources Recommend Favorite